CCL11/CCR3-dependent eosinophilia alleviates malignant pleural effusions and improves prognosis

Min Zhang1, Lixia Xia1, Wenbei Peng2

  • 1Department of Respiratory and Critical Care Medicine, Key Laboratory of Respiratory Disease of Zhejiang Province, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, 310009, Zhejiang, China.

PubMed

Insights

Eosinophils protect against malignant pleural effusion (MPE) in cancer. Increasing eosinophil numbers or transferring them improved MPE, highlighting their anti-tumor role.

Area of Science:

  • Oncology
  • Immunology
  • Pulmonology

Background:

  • Malignant pleural effusion (MPE) is common in advanced cancer with poor prognosis.
  • Eosinophils are implicated in MPE development, but their precise role is unclear.

Purpose of the Study:

  • To investigate the role of eosinophils in the development and progression of MPE.
  • To explore the therapeutic potential of eosinophils in managing MPE.

Main Methods:

  • Analysis of human MPE samples to correlate eosinophil counts with clinical scores (LENT score).
  • Studies using mouse models to observe eosinophil migration and function in the pleural cavity.
  • Investigation of the C-C motif chemokine ligand 11 (CCL11) and C-C motif chemokine receptor 3 (CCR3) pathways.

Main Results:

  • Elevated eosinophil counts in MPE patients correlated with lower LENT scores.
  • Eosinophils actively migrated to the pleural cavity in response to tumor cells in mouse models.
  • Eosinophil deficiency exacerbated MPE, suggesting an anti-tumor effect mediated by microenvironment modification.

Conclusions:

  • Eosinophils exhibit a protective role against MPE development.
  • Enhancing eosinophil numbers, via adoptive transfer or other means, can improve MPE outcomes.
  • Targeting eosinophil-related pathways may offer novel therapeutic strategies for MPE.

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
162
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
270
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
258